Zhejiang Ausun Pharmaceutical Co Ltd Total Liabilities
Zhejiang Ausun Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Zhejiang Ausun Pharmaceutical Co Ltd (603229) has total liabilities worth CN¥789.65 Million CNY (≈ $115.55 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 603229 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Zhejiang Ausun Pharmaceutical Co Ltd (2012–2025)
Total liabilities of Zhejiang Ausun Pharmaceutical Co Ltd from 2012 to 2025. This chart illustrates how Zhejiang Ausun Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data.
Zhejiang Ausun Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Zhejiang Ausun Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bank Sinarmas Tbk
JK:BSIM
|
Indonesia | Rp40.60 Trillion |
|
Southside Bancshares, Inc.
NASDAQ:SBSI
|
USA | $7.55 Billion |
|
Pentamaster Corporation Bhd
KLSE:7160
|
Malaysia | RM301.71 Million |
|
Plazza AG
SW:PLAN
|
Switzerland | CHF555.12 Million |
|
Odyssey Therapeutics, Inc. Common Stock
NASDAQ:ODTX
|
USA | $62.63 Million |
|
Hainan Development Holdings Nanhai Co Ltd
SHE:002163
|
China | CN¥4.96 Billion |
|
Gujarat Pipavav Port Limited
NSE:GPPL
|
India | Rs6.35 Billion |
|
Simply Good Foods Co
NASDAQ:SMPL
|
USA | $644.32 Million |
Liability Composition Analysis (2012–2025)
This chart breaks down Zhejiang Ausun Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 603229 total assets.
Liquidity & Leverage Metrics
Zhejiang Ausun Pharmaceutical Co Ltd Total Liabilities Ratios Explained
Zhejiang Ausun Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.64 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.33 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.25 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang Ausun Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang Ausun Pharmaceutical Co Ltd (2012–2025)
The table below shows the annual total liabilities of Zhejiang Ausun Pharmaceutical Co Ltd from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥815.89 Million ≈ $119.39 Million |
+14.83% |
| 2024-12-31 | CN¥710.50 Million ≈ $103.97 Million |
-12.28% |
| 2023-12-31 | CN¥809.99 Million ≈ $118.53 Million |
-5.17% |
| 2022-12-31 | CN¥854.19 Million ≈ $124.99 Million |
+46.11% |
| 2021-12-31 | CN¥584.64 Million ≈ $85.55 Million |
+129.44% |
| 2020-12-31 | CN¥254.81 Million ≈ $37.29 Million |
+5.75% |
| 2019-12-31 | CN¥240.96 Million ≈ $35.26 Million |
+17.90% |
| 2018-12-31 | CN¥204.38 Million ≈ $29.91 Million |
+15.70% |
| 2017-12-31 | CN¥176.65 Million ≈ $25.85 Million |
-12.88% |
| 2016-12-31 | CN¥202.76 Million ≈ $29.67 Million |
-5.17% |
| 2015-12-31 | CN¥213.81 Million ≈ $31.29 Million |
+17.54% |
| 2014-12-31 | CN¥181.90 Million ≈ $26.62 Million |
+24.70% |
| 2013-12-31 | CN¥145.87 Million ≈ $21.35 Million |
+30.00% |
| 2012-12-31 | CN¥112.21 Million ≈ $16.42 Million |
-- |
About Zhejiang Ausun Pharmaceutical Co Ltd
Zhejiang Ausun Pharmaceutical Co., Ltd. engages in the research and development, process development, manufacture, and sale of APIs and pharmaceutical intermediates. It offers fluorine products, prostaglandins, antimicrobials, and oncology products. The company also provides products for liver disease, respiratory system, and cardiac and cerebral vessels, as well as CNS indications. In addition, … Read more